Utility of OCT3/4, TSPY and β-catenin as biological markers for gonadoblastoma formation and malignant germ cell tumor development in dysgenetic gonads

Disease Markers

Volumn 34, Issue 6, 2013, Pages 419-424

  Palma, Icela ^b,c   Garibay, Nayely ^a   Pena Yolanda, Rocio ^d   Contreras, Alejandra ^d   Raya, Atlantida ^d   Dominguez, Carolina ^d   Romero, Mirna ^b   Aristi, Gerardo ^a,e   Queipo, Gloria ^a,e  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

dysgenetic gonads; Gonadoblastoma; mixed gonadal dysgenesis; OCT3 4; TSPY; catenin

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; OCTAMER TRANSCRIPTION FACTOR 4; PEPTIDES AND PROTEINS; TSPY PROTEIN; UNCLASSIFIED DRUG;

AMBIGUOUS GENITALIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GERM CELL TUMOR; GONAD; GONADAL DYSGENESIS; GONADOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENTIATION DISORDER; TUMOR GROWTH;

EID: 84878836653     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-130972     Document Type: Article

References (15)

1. AM Kersemaekers, et al., Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY, Hum Pathol 36 (2005), 512-21.
2. B Bianco, KC Oliveira, AD Guedes, et al., OCT4 gonadal gene expression related to the presence of Y-chromosome sequences in Turner syndrome, Fertil Steril 94 (2010), 2347-9.
3. F Schnieders, et al., Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues, Hum Mol Genet 5 (1996), 1801-7.
4. I Palma, et al., Participation of OCT3/4 and beta-catenin during dysgenetic gonadal malignant transformation, Cancer Lett 263 (2008), 204-11.
5. JW Oosterhuis and LH Looijenga, Testicular germ-cell tumours in a broader perspective Nat Rev Cancer 5 (2005), 210-22.
6. L Cheng, et al., OCT4: Biological functions and clinical applications as a marker of germ cell neoplasia, J Pathol 211 (2007), 1-9.
7. LH ooijenga, et al., Gonadal tumours and DSD, Best Pract Res Clin Endocrinol Metab 24 (2010), 291-310.
8. MCools, et al., Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes, J Clin Endocrinol Metab 90 (2005), 5295-303.
9. M Cools, et al., Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonad, J Clin Endocrinol Metab 91 (2006), 2404-13.
10. N Liu, et al., Genome-wide gene expression profiling reveals aberrant MAPK and Wnt signaling pathways associated with early parthenogenesis, J Mol Cell Biol, 2 (2010), 333-44.
11. R Hersmus, et al., New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD), Mol Cell Endocrinol 291 (2008), 1-10.
12. S Gidekel, et al., Oct-3/4 is a dose-dependent oncogenic fate determinant, Cancer Cell 4 (2003), 361-70.
13. Y Li, ZL Tabatabai, et al., The Y-encoded TSPY protein: A significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors, Hum Pathol 38 (2007), 1470-81.
14. Y-R Peña, K Nieto, R Alvarez, I Palma, N Nájera, L Eraña, LM, S Kofman-Alfaro, G Queipo, Distribution of Y chromosome-bearing cells in gonadoblastoma and dysgenetic testis in 45, X/46, XY infants, Mod Pathol 18 (2005), 439-45.
15. YF Lau, Y Li and T Kido, Role of the Y-located putative gonadoblastoma gene in human spermatogenesis, Syst Biol Reprod Med 57 (2011), 27-34.